PLA2G4A and acute myeloid leukemia: It has also been found that the high expression of PLA2G4A in FLT3-mutated AML is not only an indicator of poor prognosis but also related to drug resistance to tyrosine kinase inhibitors and changes in the tumor microenvironment of AML (35).